OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Rise (& Fall) Of ESAs
22 minutes
Posted Nov 21, 2018 at 5:00 pm.
0:00
22:05
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Describing the rationale for and rise in widespread ESA use for cancer patients going back 30 years....and why their use has been drastically curtailed in the last decade.
Previous
Cyclophosphamide
Next
Elderly AML & Larotrectinib
← See all 273 episodes of OncoPharm